Streetbeat News

Equity Actions

CORT

The private equity backers of the Plan B morning-after pill are considering a sale of the company, potentially valued at $4 billion, according to Bloomberg. Corcept Therapeutics (CORT) is mentioned in the article.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2023 | 5:48 pm

VOD

Vodafone has filed for a mixed shelf offering with the SEC, although the size of the offering has not been disclosed.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2023 | 5:16 pm

NIO

XPEV

NIO Inc's shares are trading higher by 9.03% despite no company-specific news. The rise is attributed to China's broad measures to optimize its business environment and the strength of peer Chinese EV maker XPeng Inc after its technical collaboration agreement with Volkswagen. The overall market volatility ahead of the Federal Reserve's decision on rate hikes also contributes to the rise.

Portfolio Pulse from Henry Khederian

July 26, 2023 | 5:08 pm

BIDU

Steve Weiss, a regular guest on CNBC, has purchased shares in Baidu (BIDU).

Portfolio Pulse from Benzinga Newsdesk

July 26, 2023 | 4:59 pm

ODFL

Old Dominion Freight Line reported mixed Q2 results and announced a new repurchase program, leading to a rise in its share prices.

Portfolio Pulse from Bill Haddad

July 26, 2023 | 4:38 pm

VIEW

View Inc. has announced a 60-for-1 reverse stock split which is expected to become effective for trading on July 27, 2023.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2023 | 4:31 pm

ALKS

JNJ

Alkermes plc reported Q2 adjusted EPS of $0.55, missing the consensus of $0.56. However, sales of $617.40 million beat the consensus estimate of $585.02 million, reflecting strong performance of proprietary products and reinstated Invega product royalties. The company increased its FY23 outlook by $425 million following a successful arbitration with Janssen Pharmaceutica N.V., a subsidiary of Johnson & Johnson. Alkermes' shares are down 4.15%.

Portfolio Pulse from Vandana Singh

July 26, 2023 | 3:58 pm

XPEV

XPeng, Inc. (NASDAQ:XPEV) has entered into a strategic partnership with the Volkswagen Group. Volkswagen will purchase 4.99% of XPENG's outstanding shares at $15 per share, totaling approximately $700 million. The companies will jointly develop two B-class battery electric vehicles for sale in China under the Volkswagen brand, leveraging XPeng's G9 platform and Connectivity and ADAS software. Production is expected to commence in 2026.

Portfolio Pulse from Erica Kollmann

July 26, 2023 | 3:45 pm

FWRG

Zacks SurpriseTrader has reportedly purchased stocks of First Watch Restaurant Group (FWRG).

Portfolio Pulse from Benzinga Newsdesk

July 26, 2023 | 3:32 pm

DPSI

Decisionpoint Systems Inc's board has approved the appointment of Melinda Wohl as the company's CFO.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2023 | 3:30 pm